Some Healthy Teens Are Given Cannabidiol for Health Reasons
By Elana Gotkine HealthDay Reporter
THURSDAY, May 30, 2024 -- About 3 percent of healthy adolescents are given commercial cannabidiol (CBD) for health reasons, according to a study published online May 7 in Cannabis and Cannabinoid Research.
Natasha E. Wade, Ph.D., from the University of California in San Diego, and colleagues described the characteristics of adolescents given health-related CBD (hCBD) and examined predictors of use using data from 11,189 adolescents aged 11 to 15 years from the Adolescent Brain Cognitive Development Study. Participants and caregivers completed questionnaires including questions on whether adolescents were given CBD with permission from a parent or doctor.
The researchers found that 2.8 percent of the participants were given hCBD, with common administration methods including oil, topical, and edibles (42, 31, and 29 percent, respectively). The odds of hCBD were increased in association with being older, being White or Hispanic versus Black, having parents with some college versus no high school diploma, and having internalizing symptoms, mental health treatment, pain, medical treatment, and sleep problems. The odds of hCBD were reduced in association with rules against recreational cannabis.
"While this study documents that about 3 percent of young teens have been given CBD for medicinal reasons, we believe this is likely an underreport," Wade said in a statement. "Parents might not be comfortable saying they're giving CBD to their kids, even though they're trying to help them."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted May 2024
Read this next
Allergy-Related Psychological Distress Common
TUESDAY, July 2, 2024 -- Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in Allergy. Rebecca C...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.